Skip to main content

Transmitter Biochemistry of Huntington’s Disease

  • Chapter

Abstract

A great deal of new data on the neurochemistry of human brain has resulted from the availability of post-mortem brain tissues from patients dying from Huntington’s disease (H.D.).

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Alzheimer, A. (1911). Huntingtoniche chorea und die choreatishen Bewegungen iberthaupt. Z. Gesamte Neurol. Psychiatr. 3:891–892.

    Google Scholar 

  • Aquilonius, S.M., Eckernas, S.A. and Sundwall, A. (1975). Regional distribution of choline acetyltransferase in human brain: changes in Huntington’s chorea. J. Neurol. Neurosurg. Psychiatry 38:669–677.

    Article  Google Scholar 

  • Arregui, A., Iversen, L.L., Spokes, E.G.S. and Emson, P.C. (1979). Alterations in postmortem brain angiotensin-converting enzyme activity and some neuropeptides in Huntington’s disease. In: Advances in Neurology (eds. T.N. Chase, N.S. Wexler and A. Barbeau), Raven Press, New York, 23:517–525.

    Google Scholar 

  • Barker, J.L. (1976). Peptides: roles in neuronal excitability. Physiol. Rev. 56:435–452.

    Google Scholar 

  • Bernheimer, H. and Hornykiewicz, O. (1973). Brain amines in Huntington’s chorea. In: Advances in Neurology (eds. A. Barbeau, T.N. Chase and G.W. Paulson), Raven Press, New York, 1:525–531.

    Google Scholar 

  • Bird, E.D. (1976). Biochemical studies on γ-aminobutyric acid metabolism in Huntington’s chorea. In: Biochemistry and Neurology (eds. H.F. Bradford and C.D. Marsden), Academic Press, London, pp. 83–91.

    Google Scholar 

  • Bird, E.D. and Iversen, L.L. (1974). Huntington’s chorea: Post-mortem measurement of glutamic acid decarboxylase, choline acetyltransference and dopamine in basal ganglia. Brain 97:457–472.

    Article  Google Scholar 

  • Bird, E.D., Chiappa, S.A. and Fink, G. (1976). Brain immunoreactive gonadotripin-releasing hormone in Huntington’s chorea and in non-choreic subjects. Nature 260:536–538.

    Article  Google Scholar 

  • Bird, E.D., Spokes, E.G.S. and Iversen L.L. (1979). Increased dopamine concentration in limbic areas of brain from patients dying with schizophrenia. Brain 102:347–360.

    Article  Google Scholar 

  • Bowen, D.M., Smith, C.B., White, P. and Davison, A.N. (1976). Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain 99:459–496.

    Article  Google Scholar 

  • Brownstein, M.J., Mroz, E.A., Tappaz, M.L. and Leeman, S.E. (1977). On the origin of substance P and glutamic acid decarboxylase (GAD) in the substantia nigra. Brain Research 135:315–323.

    Article  Google Scholar 

  • Bruyn, G.W. (1968). Diseases of the basal ganglia. In: Handbook of Clinical Neurology, (eds, P.J. Vinken and G.W. Bruyn), North-Holland Publishing Company, Amsterdam, 6:298–378.

    Google Scholar 

  • Campbell, A.M.G., Corner, B., Norman, R.M. and Urich, H. (1961). A rigid form of Huntington’s disease. J. Neurol. Neurosurg. Psychiatry 24:71–77.

    Article  Google Scholar 

  • Chase, T.N. (1973), Biochemical and pharmacological studies of monoamines in Huntington’s chorea. In: Advances in Neurology, (eds. A. Barbeau, T.N. Chase and G.W. Paulson), Raven Press, New York, 1:533–542.

    Google Scholar 

  • Curzon, G., Gumpert, J. and Sharpe, D. (1972). Amine metabolites in the cerebral spinal fluid in Huntington’s chorea. J. Neurol. Neurosurg. Psychiatry 35:514–519.

    Article  Google Scholar 

  • Curzon, G. (1975). CSF homovanillic acid: an index of dopaminergic activity. In: Advances in Neurology, (eds. D. Calne, T.N. Chase and A. Barbeau), Raven Press, New York, 9:349–357.

    Google Scholar 

  • Emson, P.C., Fahrenkrug, J. and Spokes, E.G.S. (1979). Vasoactive intestinal polypeptide (VIP): distribution in normal human brain and in Huntington’s disease. Brain Research, 173:174–178.

    Article  Google Scholar 

  • Emson, P. et al (1980). Abstract — Transmitter Biochemistry of Human Brain Tissue Symposium, Goteborg, Sweden.

    Google Scholar 

  • Folstein, S.E., Folstein, M.F. and McHugh, P.R. (1979). Psychiatric syndromes in Huntington’s disease. In: Advances in Neurology, (eds. T.N. Chase, N.S. Wexler and A. Barbeau), Raven Press, New York, 23:281–289.

    Google Scholar 

  • Gale, J.S., Bird, E.D. Spokes, E.G.S., Iversen, L.L. and Jessell, T. (1978). Human brain substance P: distribution in controls and Huntington’s chorea. J. Neurochem. 30:633–634.

    Article  Google Scholar 

  • Gibbs, J., Young, R.C. and Smith, G.P. (1973). Cholecystokinin elicits satiety in rats with open gastric fistulas. Nature 245:328–330.

    Article  Google Scholar 

  • Hokfelt, T., Ljungdahl, A., Steinbusch, H., Verhofstad, A., Nilsson, G., Brodin, E., Pernow, B. and Goldstein, M. (1978), Immunohistochemical evidence of substance-P-like immunoreactivity in some 5-hydroxytryptamine-containing neurons in the rat central nervous system. Neuroscience 3:517–538.

    Article  Google Scholar 

  • Hokfelt, T. et al (1980). Eur. J. Pharmacol. (submitted).

    Google Scholar 

  • Hornykiewicz, O. (1963). Die topische Lokalisation und das Verhalten von Noradrenalin und Dopamin (3-hydroxytyramin) in der Stubstantia nigra des normalen und Parksinson-kranken Menschen. Wien. Klin. Wschr. 75:309–312.

    Google Scholar 

  • Johansson, B. and Roos, B.E. (1975). Concentrations of monoamine metabolites in human lumbar and cisternal cerebrospinal fluid. Acta Neurol. Scand. 52: 137–144.

    Article  Google Scholar 

  • Kanazawa, I., Miyata, Y., Toyokura, Y. and Otsuka, M. (1973). The distribution of γ-aminobutyric acid (GABA) in the human substantia nigra. Brain Res. 51:363–365.

    Article  Google Scholar 

  • Kanazawa, E., Bird, E.D., O’Connell, R. and Powell, D. (1977). Evidence for a decrease in substance P content of substantia nigra in Huntington’s chorea. Brain Res. 120:387–392.

    Article  Google Scholar 

  • Kanazawa, I., Emson, P.C. and Cuello, A.C. (1977). Evidence for the existence of substance P-containing fibres in striato-nigral and pallido-nigral pathways in rat brain. Brain Res. 119:447–453.

    Article  Google Scholar 

  • Lange, H., Thorner, G., Hopf, A. and Schroder, K.F. (1976). Morphometric studies of the Neuro-pathological changes in choreatic diseases. J. Neurol. Sci. 28:401–425.

    Article  Google Scholar 

  • Lieberman, A., Dziatolowski, M., Neophytides, A., Kupersmith, M., Aleksic, S., Serby, M., Korein, J. and Goldstein, M. (1979). Dementias of Huntington’s and Parkinson’s disease. In: Advances in Neurology, (eds. T.N. Chase, N.S. Wexler, and A. Barbeau), Raven Press, New York, 23:273–280.

    Google Scholar 

  • Ljungdahl, A., Hokfelt, T., Nilsson, G. and Goldstein, M. (1978). Distribution of substance P-like immunoreactivity in the central nervous system of the rat-II. Light microscopic localization in relation to catecholamine-containing neurons. Neuroscience 3:945–976.

    Article  Google Scholar 

  • Manyam, N.J., Hare, T.A., Katz, L. and Glaeser, B.S. (1978). Huntington’s disease. Cerebrospinal fluid GABA levels in at-risk individuals. Arch. Neurol. 35:728–730.

    Article  Google Scholar 

  • McGeer, P.L. and McGeer, E.G. (1976). Enzymes associated with the metabolism of catecholamines, acetylcholine and GABA in human controls and patients with Parkinson’s disease and Huntington’s chorea. J. Neurochem. 26:65–76.

    Google Scholar 

  • Okon, E. and Koch, Y. (1976). Nature 263:345–347.

    Google Scholar 

  • Oliver, J.E. (1970). Huntington’s chorea in Northamptonshire. Br. J. Psychiatry 116:241.

    Article  Google Scholar 

  • Perry, E.K., Gibson, P.N., Blessed, G., Perry, R.H. and Tomlinson, B.E. (1977). Neurotransmitter enzyme abnormalities in senile dementia. J. Neurol. Sci. 34:247–265.

    Article  Google Scholar 

  • Perry, T.L., Hansen, S. and Kloster, M. (1973). Huntington’s chorea: deficiency of γ-aminobutyric acid in brain, N. Eng. J. Med. 288:337–342.

    Article  Google Scholar 

  • Perry, T.L., Buchanan, J., Kish, S.J. and Hansen, S. (1979). γ-aminobutyric acid deficiency in brain of schizophrenic patients. Lancet i:237–239.

    Article  Google Scholar 

  • Reed, T.E. and Neel, J.V. (1959). Huntington’s chorea in Michigan. II. Selection and mutation. Amer. J. Hum. Genet. II: 107–136.

    Google Scholar 

  • Rehfeld, J.F. (1978). Immunochemical studies on cholecystokinin. J. Biol. Chem. 253:11, 4022–4030.

    Google Scholar 

  • Rehfeld, J.F. (1980). Cholecystokinin. Trends in Neuro-Sciences 3:65–67.

    Article  Google Scholar 

  • Reisine, T.D., Fields, J.Z., Bird, E.D., Spokes, E. and Yamamura, H.I. (1978). Characterization of brain dopaminergic receptors in Huntington’s disease. Commun. Psychopharmac. 2:79–84.

    Google Scholar 

  • Robberecht, P., Deschodt-Lanckman, M. and Vanderhaeghen, J.J. (1978). Demonstration of biological activity of brain gastrin-like peptidic material in the human: Its relationship with the COOH-terminal octa-peptide of cholecystokinin. Proc. Natl. Acad. Sci. USA 75:1, 524–528.

    Article  Google Scholar 

  • Spokes, E.G.S., Garrett, N.J. and Iversen, L.L. (1979). Differential effects of agonal status on measurements of GABA and glutamate decarboxylase in human post-mortem brain tissue from control and Huntington’s chorea subjects. J. Neurochem. 33: 773–778.

    Article  Google Scholar 

  • Spokes, E.G.S. (1980). Neurochemical alterations in Huntington’s chorea — A study of post-mortem brain tissue. Brain 103:179–210.

    Article  Google Scholar 

  • Tellez-Nagel, I., Johnson, A.B. and Terry, R.D. (1973). Ultrastructural and histochemical study of cerebral biopsies in Huntington’s chorea. In: Advances in Neurology (eds. A. Barbeau, T.N. Chase and G.W. Paulson), Raven Press, New York, 1:387–398.

    Google Scholar 

  • Vanderhaeghen, J.J., Signeau, J.C. and Gepts, W. (1975). New peptide in the vertebrate CNS reacting with antigastrin antibodies. Nature 257:604–605.

    Article  Google Scholar 

  • Wallace, D.C. (1974). Huntington’s chorea in Queensland. A not uncommon disease. Med. J. Aust. 39:375.

    Google Scholar 

  • Wendt, G.G. and Drohm, D. (1972). (Huntington’s chorea. A population-genetic study). In: Humangenetik: Advances in Human Genetics, Theime, Stuttgart, 4:1–121.

    Google Scholar 

  • Westphal, A. (1905). Case Report, Zbl. Nervenheilk 28:674–675.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Copyright information

© 1981 The Contributors

About this chapter

Cite this chapter

Bird, E.D., Kraus, L.J. (1981). Transmitter Biochemistry of Huntington’s Disease. In: Riederer, P., Usdin, E. (eds) Transmitter Biochemistry of Human Brain Tissue. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-05932-4_15

Download citation

Publish with us

Policies and ethics